Patents by Inventor Karina Martha Langseth

Karina Martha Langseth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414792
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Application
    Filed: May 18, 2023
    Publication date: December 28, 2023
    Inventors: Karina Martha LANGSETH-MANRIQUE, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen
  • Patent number: 11730832
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Grant
    Filed: October 26, 2020
    Date of Patent: August 22, 2023
    Assignee: GE HEALTHCARE AS
    Inventors: Karina Martha Langseth-Manrique, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen
  • Patent number: 11724022
    Abstract: Disclosed herein are novel procedures, systems and excipient solutions for in situ provision of a contrast media at a user defined concentrations. An automated procedure according to embodiments of the current invention provides increased user safety, flexibility and user friendliness.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: August 15, 2023
    Assignee: GE HEALTHCARE AS
    Inventors: Karina Martha Langseth-Manrique, Duncan Wynn
  • Publication number: 20210069355
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Application
    Filed: October 26, 2020
    Publication date: March 11, 2021
    Inventors: Karina Martha LANGSETH-MANRIQUE, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen
  • Publication number: 20200390965
    Abstract: Disclosed herein are novel procedures, systems and excipient solutions for in situ provision of a contrast media at a user defined concentrations. An automated procedure according to embodiments of the current invention provides increased user safety, flexibility and user friendliness.
    Type: Application
    Filed: December 20, 2018
    Publication date: December 17, 2020
    Inventors: Karina Martha LANGSETH-MANRIQUE, Duncan WYNN
  • Patent number: 10842888
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: November 24, 2020
    Assignee: GE Healthcare AS
    Inventors: Karina Martha Langseth-Manrique, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen
  • Publication number: 20180207297
    Abstract: The present invention provides a method for the commercial presentation of a solution of gadolinium-DOTA that provides certain advantages over the known methods.
    Type: Application
    Filed: January 22, 2018
    Publication date: July 26, 2018
    Applicant: GE HEALTHCARE AS
    Inventors: Karina Martha Langseth-Manrique, Arne Wang Aabye, Harald Laugen, Eva Krog Tamnes, Borge Mathisen
  • Patent number: 9291606
    Abstract: A quality control (“QC”) system for PET or SPECT radiopharmaceuticals is disclosed that contains a disposable, no-leakage, self-contained QC cassette, which interfaces with the QC system. The QC system may include a shield that substantially surrounds the cassette such that the area and the cassette are both shielded. The QC cassette may contain shielding also. The QC cassette contains components for conducting one or more QC tests. These components include sensor and devices for performing various QC tests on radiopharmaceuticals. The QC system may contain a number of sub-systems and devices for supporting the QC tests. The QC system may produce a QC report containing the test results.
    Type: Grant
    Filed: August 22, 2011
    Date of Patent: March 22, 2016
    Assignee: GENERAL ELECTRIC COMPANY
    Inventors: Ole Henrik Hansteen, Jan Borge Jakobsen, Svein-Erik Lindgaard, Xavier Franci, Line Roed, Arnfinn Andersen, Gro Johansen, Torsten Knuttel, Karina Martha Langseth
  • Publication number: 20130337493
    Abstract: A quality control (“QC”) system for PET or SPECT radiopharmaceuticals is disclosed that contains a disposable, no-leakage, self-contained QC cassette, which interfaces with the QC system. The QC system may include a shield that substantially surrounds the cassette such that the area and the cassette are both shielded. The QC cassette may contain shielding also. The QC cassette contains components for conducting one or more QC tests. These components include sensor and devices for performing various QC tests on radiopharmaceuticals. The QC system may contain a number of sub-systems and devices for supporting the QC tests. The QC system may produce a QC report containing the test results.
    Type: Application
    Filed: August 22, 2011
    Publication date: December 19, 2013
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Ole Henrik Hansteen, Jan Borge Jakobsen, Svein-Erik Lindgaard, Xavier Franci, Line Roed, Arnfinn Andersen, Gro Johansen, Torsten Knuttel, Karina Martha Langseth